About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Pfizer Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
500680
ISIN Demat
INE182A01018
Book Value
847.79
NSE Code
PFIZER
Dividend Yield %
0.86
Market Cap
186643.88
P/E
30.32
EPS
134.55
Face Value
10
BSE
NSE
11-Apr-2025
BSE
NSE
NSE F & O
11-Apr-2025 15:56
BSE
NSE
NSE F & O
Last Price
4079.85
Net Change
45.3
% Change
1.12%
Prev.Close
4034.55
Open
4165.45
High
4165.45
Low
4007.15
Volume
1579
Last Price
4080.25
Net Change
45.35
% Change
1.12%
Prev.Close
4034.90
Open
4115.60
High
4115.60
Low
4001.20
Volume
19928
Value
6419080
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
4165.45
52-Week High
6452.85
52-Week Low
3742.90
Value
81311222
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
4115.60
52-Week High
6451.15
52-Week Low
3701.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
13-Aug-21
19-Aug-21
Dividend
350 %
21-Aug-24
Company News
19-03-2025
Pfizer informs about disc...
24-02-2025
Pfizer zooms on getting n...
21-02-2025
Pfizer gets nod to enter ...
04-02-2025
Pfizer informs about disc...
11-12-2024
Pfizer informs about issu...
08-08-2024
Pfizer informs about news...
27-05-2024
Pfizer informs about annu...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.